Principal Financial Group’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Principal Financial Group’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-10,218	Closed	-$357K	–	2513
2024 Q1	$357K	Sell	10,218 -150	-1%	-$5.47K	﹤0.01%	2057
2023 Q4	$394K	Sell	10,368 -403	-4%	-$8.63K	﹤0.01%	2003
2023 Q3	$198K	Buy	10,771 +428	+4%	+$8.96K	﹤0.01%	2170
2023 Q2	$269K	Buy	+10,343	New	+$242K	﹤0.01%	2102
2023 Q1	–	Sell	-9,950	Closed	-$245K	–	2541
2022 Q4	$245K	Buy	+9,950	New	+$292K	﹤0.01%	2147
2022 Q1	–	Sell	-4,748	Closed	-$207K	–	2636
2021 Q4	$207K	Buy	+4,748	New	+$190K	﹤0.01%	2356

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Principal Financial Group's INBX Position: Q2 2024 in Review

Principal Financial Group sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 10,218 shares — an estimated $357K sold.

Principal Financial Group first reported a position in INBX in Q4 2021 and held it in 6 quarters. The position peaked at $394K in Q4 2023. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

Principal Financial Group reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Principal Financial Group sold 10,218 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $357K.
Principal Financial Group first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
Principal Financial Group's Inhibrx, Inc. Common Stock position peaked at $394K in Q4 2023.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on Principal Financial Group's 13F filing for Q2 2024, filed 29 Jul 2024.